Moderna announced Wednesday that the first participant has been dosed in the company's Phase 2 clinical trial of a coronavirus vaccine booster shot that is specific to the Omicron variant.
Moderna promises to share its data from the trial with public health leaders so they can make evidence-based decisions on the best booster strategy against the coronavirus going forward. A study published Wednesday says the Moderna Covid-19 booster shot remains durable against the Omicron variant, but the antibody protection wanes and is six times lower six months after getting boosted.
Research teams from Moderna, Duke University, Emory University, the Fred Hutchinson Cancer Research Center, the Baylor College of Medicine, the University of Maryland School of Medicine and the National Institutes of Health looked at blood samples from adults who had two doses of the Moderna vaccine, as well as those who also had a booster dose. Some of those were boosted with the 50-microgram dose and some at 100-μg levels. The current booster is authorized at the 50-μg level.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Two-thirds of Omicron cases in England reinfections — studyNearly two-thirds of people in England who tested positive for COVID-19 in January previously had the virus or suspected they had it, a large long-running infection survey revealed Wednesday.
Source: gmanews - 🏆 11. / 68 Read more »
Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots — studyA third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac’s CoronaVac shot, a study has found.
Source: interaksyon - 🏆 24. / 51 Read more »
Omicron survives longer on plastic, skin than prior variants, study showsThe Omicron variant can survive longer than earlier versions of the coronavirus on plastic surfaces and human skin, Japanese researchers found in laboratory tests.
Source: gmanews - 🏆 11. / 68 Read more »
Pfizer-BioNTech begin Omicron vaccine trialThe company’s head of vaccine research Kathrin Jansen said in a statement that while current data showed that boosters against the original Covid strain continued to protect against severe outcomes with Omicron, the company was acting out of caution. Why would they spend so much money and time creating another one if the one they are using is supposedly working? This is nonsense.
Source: manilabulletin - 🏆 25. / 51 Read more »
Do not assume COVID pandemic reaching 'end game', warns WHOTedros warns against lurching between 'panic and neglect' Pandemic in third year, with nearly 6 million dead More variants likely to follow Omicron, WHO
Source: interaksyon - 🏆 24. / 51 Read more »
'Pre-Omicron' protocols pushed for arriving international travelersPresidential Adviser for Entrepreneurship and Go Negosyo founder Joey Concepcion has made an aggressive pitch for the government to return to “pre-Omicron” protocols, especially when it comes to arriving international travelers.
Source: manilabulletin - 🏆 25. / 51 Read more »